Clinical Trials Directory

Trials / Completed

CompletedNCT00691769

Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia

Status
Completed
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Wake Forest University · Academic / Other
Sex
Female
Age
30 Years
Healthy volunteers
Accepted

Summary

The purpose of this research study is to see if a specific protein that we are interested in is involved in scarring hair loss. If these proteins are involved, further genetic work may also better define the disease as well as future treatment options.

Detailed description

This is a single-center study, designed to evaluate the expression of Fas protein in skin biopsies of patients with scarring alopecia including fourteen patients with central centrifugal scarring alopecia (CCSA), three patients with lichen planopilaris (LP) and three patients with discoid lupus erythematosus (DLE). Skin biopsies of five healthy participants will be used as controls.

Conditions

Timeline

Start date
2006-04-26
Primary completion
2012-11-26
Completion
2012-11-26
First posted
2008-06-05
Last updated
2018-07-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00691769. Inclusion in this directory is not an endorsement.